Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 01/02/2012
PIL Lyrica Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/06/2011 and displayed until 01/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 13/09/2010 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to drug interactions
Updated on 29/06/2010 and displayed until 13/09/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/05/2010 and displayed until 29/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/03/2010 and displayed until 12/05/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/09/2009 and displayed until 01/03/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/01/2009 and displayed until 04/09/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/05/2008 and displayed until 16/01/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/03/2008 and displayed until 08/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 23/07/2007 and displayed until 25/03/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 14/06/2007 and displayed until 23/07/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 07/02/2007 and displayed until 14/06/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Addition of Marketing Authorisation Holder
Updated on 25/09/2006 and displayed until 07/02/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Extra statutory information
  • Change to Marketing Authorisation Holder
  • Change to warnings or special precautions for use
Updated on 21/08/2006 and displayed until 25/09/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/06/2006 and displayed until 21/08/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change to date of revision
Updated on 21/04/2006 and displayed until 07/06/2006
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to drug interactions
  • Change to warnings or special precautions for use
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
  • Correction of spelling/typing errors
  • Change to date of revision
Updated on 05/01/2006 and displayed until 21/04/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/07/2005 and displayed until 05/01/2006
Reasons for adding or updating:
  • Addition of joint PIL covering all presentations
  • Change to packaging
Updated on 10/05/2005 and displayed until 25/07/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 17/11/2004 and displayed until 10/05/2005
Reasons for adding or updating:
  • Change to packaging
Updated on 26/07/2004 and displayed until 17/11/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  pregabalin